Atomistry » Fluorine » PDB 6e69-6elo
Atomistry »
  Fluorine »
    PDB 6e69-6elo »
      6e69 »
      6e6j »
      6e70 »
      6e73 »
      6e78 »
      6e8q »
      6e9p »
      6ea1 »
      6ea2 »
      6ea4 »
      6eaa »
      6eab »
      6eb7 »
      6ebe »
      6ebr »
      6ebw »
      6ecz »
      6eda »
      6edl »
      6ee2 »
      6ee3 »
      6ee4 »
      6ee6 »
      6eea »
      6eed »
      6eee »
      6eeh »
      6eeo »
      6eg9 »
      6ega »
      6ehu »
      6ei4 »
      6eim »
      6eis »
      6ekh »
      6el5 »
      6el6 »
      6el7 »
      6el9 »
      6elo »

Fluorine in PDB, part 140 (files: 5561-5600), PDB 6e69-6elo

Experimental structures of coordination spheres of Fluorine (F) in bioorganic molecules from X-Ray and NMR experiments. Coordination spheres were calculated with 5.0 Angstroms radius around Fluorine atoms. PDB files: 5561-5600 (PDB 6e69-6elo).
  1. 6e69 (F: 4) - Ortho-Substituted Phenyl Sulfonyl Fluoride and Fluorosulfate As Potent Elastase Inhibitory Fragments
  2. 6e6j (F: 6) - BRD2_BROMODOMAIN2 Complex with Inhibitor 744
  3. 6e70 (F: 4) - Structure of Wild Type Human Transthyretin in Complex with Diflunisal
    Other atoms: Ca (2);
  4. 6e73 (F: 4) - Structure of Human Transthyretin VAL30MET Mutant in Complex with Diflunisal
  5. 6e78 (F: 4) - Structure of Human Transthyretin ASP38ALA Mutant in Complex with Diflunisal
  6. 6e8q (F: 2) - S. Cerevisiae CYP51 Complexed with Posaconazole
    Other atoms: Fe (1);
  7. 6e9p (F: 12) - Crystal Structure of Tryptophan Synthase From M. Tuberculosis - Open Form with BRD0059 Bound
  8. 6ea1 (F: 7) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6DA) and Catalytic Zinc Ion
    Other atoms: Mg (4); Zn (1);
  9. 6ea2 (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6H) and Catalytic Zinc Ion
    Other atoms: Mg (4); Zn (1);
  10. 6ea4 (F: 6) - ERAP2 Bound to Aryl Sulfonamide Uncompetitive Inhibitor
    Other atoms: Zn (2);
  11. 6eaa (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6I) and Catalytic Zinc Ion
    Other atoms: Mg (3); Zn (1);
  12. 6eab (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6J) and Catalytic Zinc Ion
    Other atoms: Mg (4); Zn (1);
  13. 6eb7 (F: 3) - Yycf Homologue (SP1227) Receiver Domain Activated By BEF3
    Other atoms: Mn (1);
  14. 6ebe (F: 3) - Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII and Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
    Other atoms: Zn (1);
  15. 6ebr (F: 3) - Activation of RR02 Bound to BEF3
    Other atoms: Mn (1);
  16. 6ebw (F: 1) - Halk in Complex with Compound 9 (6-(((1S)-1-(5-Fluoropyridin-2-Yl) Ethyl)Amino)-1-(3-Methyl-1H-Pyrazol-5-Yl)-1H-Pyrrolo[2,3-B]Pyridin-3- Yl)(Morpholin-4-Yl)Methanone
  17. 6ecz (F: 5) - Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII and Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
    Other atoms: Zn (1);
  18. 6eda (F: 3) - Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII and Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
    Other atoms: Zn (1);
  19. 6edl (F: 2) - Halk in Complex with Compound 1 (S)-N-(1-(2,4-Difluorophenyl)Ethyl)-3- (3-Methyl-1H-Pyrazol-5-Yl)Imidazo[1,2-B]Pyridazin-6-Amine
  20. 6ee2 (F: 36) - X-Ray Crystal Structure of Pf-M17 in Complex with Inhibitor 6I and Regulatory Zinc Ion
    Other atoms: Zn (12);
  21. 6ee3 (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6K) and Catalytic Zinc Ion
    Other atoms: Mg (4); Zn (1);
  22. 6ee4 (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6M) and Catalytic Zinc Ion
    Other atoms: Mg (5); Zn (1);
  23. 6ee6 (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6O) and Catalytic Zinc Ion
    Other atoms: Mg (3); Zn (1);
  24. 6eea (F: 6) - Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII and Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
    Other atoms: Zn (1);
  25. 6eed (F: 3) - X-Ray Crystal Structure of Pf-M1 in Complex with Inhibitor (6P) and Catalytic Zinc Ion
    Other atoms: Mg (4); Zn (1);
  26. 6eee (F: 36) - X-Ray Crystal Structure of Pf-M17 in Complex with Inhibitor (6K) and Regulatory Zinc Ion
    Other atoms: Zn (12);
  27. 6eeh (F: 15) - Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII and Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
    Other atoms: Zn (1);
  28. 6eeo (F: 1) - Bioreductive 4-Hydroxy-3-Nitro-5-Ureido-Benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII and Show Hypoxia-Enhanced Cytotoxicity Against Human Cancer Cell Lines.
    Other atoms: Zn (1);
  29. 6eg9 (F: 6) - IRAK4 in Complex with Ponatinib
    Other atoms: Co (4);
  30. 6ega (F: 6) - IRAK4 in Complex with A Type II Inhibitor
    Other atoms: Co (6);
  31. 6ehu (F: 18) - The Crystal Structure of CK2ALPHA in Complex with Compound 32
  32. 6ei4 (F: 2) - Crystal Structure of Tyrosinase From Bacillus Megaterium with B5N Inhibitor in the Active Site
    Other atoms: Cu (4);
  33. 6eim (F: 8) - Human STK10 Bound to GW683134A
  34. 6eis (F: 16) - DYRK1A in Complex with Jwc-055
  35. 6ekh (F: 3) - Crystal Structure of Activated Chey From Methanoccocus Maripaludis
    Other atoms: Mg (1);
  36. 6el5 (F: 1) - Estimation of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
    Other atoms: Cl (1);
  37. 6el6 (F: 1) - Glucocorticoid Receptor in Complex with Compound 4
  38. 6el7 (F: 2) - Glucocorticoid Receptor in Complex with Compound 31
    Other atoms: Br (1);
  39. 6el9 (F: 2) - Glucocorticoid Receptor in Complex with AZD9567
  40. 6elo (F: 1) - Estimation of Relative Drug-Target Residence Times By Random Acceleration Molecular Dynamics Simulation
Page generated: Sat Sep 28 20:10:18 2024

Last articles

Na in 4J7V
Na in 4J9M
Na in 4J3F
Na in 4J4T
Na in 4J49
Na in 4J4B
Na in 4J5Y
Na in 4J43
Na in 4J3G
Na in 4J3I
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy